Table 3.
Univariable CSM | Multivariable CSM | ||||||
---|---|---|---|---|---|---|---|
HR | [95% CI] | p-value | HR | [95% CI] | p-value | ||
Biopsy Result | Positive | 2.14 | [1.28 – 3.61] | 0.004 | 2.00 | [1.11 – 3.62] | 0.022 |
Negative | REF | REF | |||||
Gleason Score | >=7 | 4.07 | [2.01 – 8.23] | <.001 | 3.60 | [1.74 – 7.44] | <.001 |
<=6 | REF | REF | |||||
Pre-RT PSA (ng/mL) | >=20 | 1.68 | [0.93 – 3.04] | 0.021 | 1.43 | [0.78 – 2.61] | 0.25 |
10–20 | 0.61 | [0.31 – 1.20] | 0.57 | [0.29 – 1.13] | 0.11 | ||
0–10 | REF | REF | |||||
T-Stage | T3 | 1.34 | [0.72 – 2.50] | 0.35 | 1.05 | [0.55 – 2.02] | 0.87 |
T1-T2 | REF | REF | |||||
Hormones | No | 0.89 | [0.53 – 1.48] | 0.65 | 0.91 | [0.51 – 1.63] | 0.75 |
Yes | REF | REF | |||||
NCCN Risk Score | High | 5.56 | [1.35 – 22.96] | 0.007 | --- | ||
Medium | 2.87 | [0.68 – 12.20] | --- | ||||
Low | REF | --- |